文献速递脑血管病外科神经重症

动脉瘤性蛛网膜下腔出血患者脑脊液白细胞介素-6的病程变化及临床相关性

The Course and Clinical Relevance of Interleukin-6 in Cerebrospinal Fluid in Patients with Aneurysmal Subarachnoid Hemorrhage.
PubMed 文献 · World Neurosurg · 2025-03-04

该研究连续纳入2005年1月至2016年6月期间接受规律脑脊液IL-6检测的420例动脉瘤性蛛网膜下腔出血患者,每72小时记录IL-6水平至第19-21天。结果显示IL-6在d4-6出现初始升高(中位数3121 vs d1-3的1467 pg/mL),随后逐渐下降;d1-3的IL-6与院内死亡和不良结局相关,d4-6的IL-6与迟发性脑梗死和院内死亡相关。

要点

  • 脑脊液IL-6在出血后d4-6达峰值(中位数3121 pg/mL),随后逐渐下降
  • d1-3 IL-6>2000 pg/mL独立关联院内死亡(aOR=2.67)和不良结局(aOR=2.30)
  • d4-6 IL-6>2500 pg/mL独立关联院内死亡(aOR=2.28)和迟发性脑梗死(aOR=1.64)

核心结论

  • 数据证实神经炎症对动脉瘤性蛛网膜下腔出血具有重要影响,出血后第一周内测得的脑脊液IL-6值是最有价值的结局预测指标。

研究设计与样本

  • 连续纳入2005年1月至2016年6月期间接受规律脑脊液IL-6检测的动脉瘤性蛛网膜下腔出血患者420例,每72小时记录IL-6水平(从d1-3至d19-21)。

主要发现

  • IL-6在d4-6出现初始升高(中位数3121 vs d1-3的1467 pg/mL),随后在剩余时间内逐渐下降。
  • d1-3的IL-6值与院内死亡和不良结局相关,d4-6的IL-6与迟发性脑梗死风险和院内死亡相关。
  • 多因素分析中,d1-3 IL-6>2000 pg/mL独立关联院内死亡(aOR=2.67;P=0.009)和不良结局(aOR=2.30;P=0.006)。
  • d4-6 IL-6>2500 pg/mL独立关联院内死亡(aOR=2.28;P=0.017)和迟发性脑梗死(aOR=1.64;P=0.044)。
  • 合并血管造影血管痉挛的SAH患者从d1-3至d4-6的IL-6升高幅度显著大于无血管痉挛者(+1770.5 vs -21 pg/mL;P=0.02)。

关键数值与推荐

  • d1-3 IL-6的临床相关截断值为>2000 pg/mL,d4-6为>2500 pg/mL(依据受试者工作特征曲线确定)。
  • 不良结局定义为出血后6个月改良Rankin量表>3。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The neuroinflammatory response to aneurysmal subarachnoid hemorrhage (SAH) might have a crucial impact on the burden of disease. We aimed to analyze the behavior of interleukin-6 (IL-6) in cerebrospinal fluid (CSF) during SAH and its relation to complications and outcomes. METHODS: We included consecutive SAH patients with regular CSF IL-6 measurements treated between January 2005 and June 2016 (n = 420). IL-6 levels were recorded every 72 hours (from day 1-3 [d1-3] until day 19-21 [d19-21]). Study endpoints were delayed cerebral infarction (DC-infarction), in-hospital mortality, and unfavorable outcome at 6 months after SAH (modified Rankin scale >3). RESULTS: There was an initial increase of IL-6 on d4-6 (median: 3121 vs. 1467 pg/mL on d1-3), with a gradual decrease over the remaining time. The IL-6 value on d1-3 showed associations with in-hospital mortality and unfavorable outcomes, whereas IL-6 on d4-6 was related to the risk of DC-infarction and in-hospital mortality. According to receiver operating characteristic curves, clinically relevant cutoffs were defined for IL-6 on d1-3 (>2000 pg/mL) and d4-6 (>2500 pg/mL). In multivariate analysis, IL-6 >2000 pg/mL on d1-3 was independently associated with in-hospital mortality (adjusted odds ratio [aOR = 2.67; P = 0.009) and unfavorable outcome (aOR=2.30; P = 0.006). In turn, IL-6 >2500 pg/mL on d4-6 was independently associated with in-hospital mortality (aOR = 2.28; P = 0.017) and DC-infarction (aOR = 1.64; P = 0.044). SAH individuals with angiographic vasospasm showed marked elevation of IL-6 from d1-3 to d4-6 compared to their counterparts without vasospasm (+1770.5 vs. -21 pg/mL; P = 0.02). CONCLUSIONS: Our data confirm the substantial impact of neuroinflammation on SAH. CSF IL-6 values measured during the first week after SAH occurrence present the most valuable outcome predictors.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ketelauri P, Gümüs M, Gull HH, et al. The Course and Clinical Relevance of Interleukin-6 in Cerebrospinal Fluid in Patients with Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2025. PMID: 39924108. doi:10.1016/j.wneu.2025.123749

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。